Cheaper, Smaller Doses of $200,000 Cancer Drugs Could Save Lives—But Big Pharma Won’t Budge
In oncology wards across the world, a quiet medical experiment is underway that could reshape the economics of cancer care. Doctors are
by 
Josh Weiner
Josh Weiner
